We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 84

Senate Committee releases final report on Prescription Pharmaceuticals in Canada
  • Stikeman Elliott LLP
  • Canada
  • March 30 2015

On March 10, 2015, the Standing Senate Committee on Social Affairs, Science and Technology (the Committee) released a final report entitled


Health Canada finalizes Risk Assessment Framework for the Consumer Product Safety Program
  • Stikeman Elliott LLP
  • Canada
  • March 24 2015

As previously reported at the consultation stage, Health Canada has completed its process of developing a Risk Assessment Framework (the Framework


Snoops and gossips beware: Ontario Government to introduce stiffer measures to protect patient privacy
  • Stikeman Elliott LLP
  • Canada
  • June 26 2015

Recently, the Government of Ontario announced its intent to strengthen the rules protecting patient privacy. If passed, these amendments to the


Health Canada publishes guidance for industry on the reporting of incidents involving consumer products
  • Stikeman Elliott LLP
  • Canada
  • July 13 2015

On July 8, 2015, Health Canada released important guidance designed to help consumer product companies, including retailers, understand their


Supreme Court of Canada affirms constitutionality of provincial breathalyzer laws
  • Stikeman Elliott LLP
  • Canada
  • October 22 2015

The Supreme Court released its decision on October 16, 2015 in the case of Goodwin v. British Columbia (Superintendent of Motor Vehicles) dealing


B.C. Court dismisses proposed class action against generic manufacturers of fentanyl patch
  • Stikeman Elliott LLP
  • Canada
  • July 8 2014

On June 20, 2014, Justice Bracken of the British Columbia Supreme Court dismissed a proposed class action against two generic manufacturers of


Government seeks feedback on new drug safety initiatives
  • Stikeman Elliott LLP
  • Canada
  • May 6 2015

As previously reported, the Food and Drugs Act (the Act) has been substantively amended by Bill C-17, also known as Vanessa's Law; the Bill received


Bill C-17 (Vanessa’s Law) receives third reading
  • Stikeman Elliott LLP
  • Canada
  • October 24 2014

Bill C-17, An Act to Amend the Foods and Drugs Act (Vanessa's Law) has proceeded through the committee process without amendment and was read for a


Health Canada releases guidance on “danger to human health or safety” posed by consumer products
  • Stikeman Elliott LLP
  • Canada
  • December 20 2013

Health Canada has released a guidance document on factors it will consider when determining whether a consumer product poses a "danger to human


Court of Appeal clarifies - for utility the promise of the patent must be "clear and unambiguous"
  • Stikeman Elliott LLP
  • Canada
  • August 21 2013

On July 24, 2013, the Federal Court of Appeal (FCA) issued its decision in Apotex Inc. v. Sanofi-Aventis, overturning a Federal Court decision